TY - JOUR T1 - An optimal set of inhibitors for Reverse Engineering via Kinase Regularization JF - bioRxiv DO - 10.1101/2020.09.26.312348 SP - 2020.09.26.312348 AU - Scott Rata AU - Jonathan Scott Gruver AU - Natalia Trikoz AU - Alexander Lukyanov AU - Janelle Vultaggio AU - Michele Ceribelli AU - Craig Thomas AU - Taran Singh Gujral AU - Marc W. Kirschner AU - Leonid Peshkin Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/09/28/2020.09.26.312348.abstract N2 - We present a comprehensive resource of 257 kinase inhibitor profiles against 365 human protein kinases using gold-standard kinase activity assays. We show the utility of this dataset with an improved version of Kinome Regularization (KiR) to deconvolve protein kinases involved in a cellular phenotype. We assayed protein kinase inhibitors against more than 70% of the human protein kinome and chose an optimal subset of 58 inhibitors to assay at ten doses across four orders of magnitude. We demonstrate the effectiveness of KiR to identify key kinases by using a quantitative cell migration assay and updated machine learning methods. This approach can be widely applied to biological problems for which a quantitative phenotype can be measured and which can be perturbed with our set of kinase inhibitors.Competing Interest StatementThe authors have declared no competing interest. ER -